Pharmacotherapy for obesity--promise and uncertainty.
Yanovski
Susan Z
SZ
D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use; D063387:Cannabinoid Receptor Antagonists; D003503:Cyclobutanes / Q000627:therapeutic use*; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D000077285:Rimonabant; D015431:Weight Loss / Q000187:drug effects
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D063387:Cannabinoid Receptor Antagonists; D003503:Cyclobutanes; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant; C058254:sibutramine